ICAHN School of Medicine At Mount Sinai
- Country
- ๐บ๐ธUnited States
- Ownership
- Private, Subsidiary
- Established
- 1963-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.mssm.edu
Investigation of a 3 oz Water Protocol on Patients With Tracheostomies
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 80
- Registration Number
- NCT06120790
- Locations
- ๐บ๐ธ
Mount Sinai Hospital, New York, New York, United States
Family-Based Interoceptive Exposure for Avoidant Restrictive Food Intake Disorder
- Conditions
- Interventions
- First Posted Date
- 2023-11-01
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 57
- Registration Number
- NCT06110806
- Locations
- ๐บ๐ธ
Department of Psychiatry, Eating and Weight Disorders Program, New York, New York, United States
Spesolimab in Pyoderma Gangrenosum
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 20
- Registration Number
- NCT06092216
- Locations
- ๐บ๐ธ
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
- Conditions
- Interventions
- First Posted Date
- 2023-10-18
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 21
- Registration Number
- NCT06088771
- Locations
- ๐บ๐ธ
Icahn School of Medicine at Mount Sinai, New York, New York, United States
The Computational and Neural Mechanisms Linking Decision-making and Memory in Humans
- Conditions
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2023-11-15
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 25
- Registration Number
- NCT06072378
Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 15
- Registration Number
- NCT06069843
- Locations
- ๐บ๐ธ
Icahn School of Medicine at Mount Sinai (Depression and Anxiety Center), New York, New York, United States
Maternal And Infant Antipsychotic Study
- Conditions
- Interventions
- First Posted Date
- 2023-09-22
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 200
- Registration Number
- NCT06049953
- Locations
- ๐บ๐ธ
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
- Conditions
- Interventions
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 54
- Registration Number
- NCT06040970
- Locations
- ๐บ๐ธ
Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology, New York, New York, United States
CTSN Embolic Protection Trial
- Conditions
- Interventions
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 842
- Registration Number
- NCT06027788
- Locations
- ๐บ๐ธ
Maine Medical Center, Portland, Maine, United States
๐บ๐ธMassachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธDuke University, Durham, North Carolina, United States
PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea
- Conditions
- Interventions
- First Posted Date
- 2023-08-28
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 66
- Registration Number
- NCT06013371
- Locations
- ๐บ๐ธ
Icahn School of Medicine at Mount Sinai, New York, New York, United States